Biotech SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference August 2, 2022
Biotech Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference August 2, 2022
Biotech Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation August 1, 2022
Biotech Bionano Genomics Announces its Participation at the Cancer Genomics Consortium 2022 Annual Meeting with 18 OGM Presentations Covering the Cancer Genomics Landscape August 1, 2022
Biotech MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older August 1, 2022
Biotech BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial August 1, 2022
Biotech Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Cassava, and Hannon Armstrong and Encourages Investors to Contact the Firm August 1, 2022
Biotech BridgeBio Pharma and Sentynl Therapeutics Receive Positive CHMP Opinion for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A August 1, 2022
Biotech Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent August 1, 2022
Search
Biotech
August 2, 2022
August 2, 2022
August 2, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
August 1, 2022
